miR-148a and miR-30a limit HCV-dependent suppression of the lipid droplet protein, ADRP, in HCV infected cell models
dc.Affiliation | October University for modern sciences and Arts (MSA) | |
dc.contributor.author | El-Ekiaby N.M. | |
dc.contributor.author | Mekky R.Y. | |
dc.contributor.author | Riad S.E. | |
dc.contributor.author | Elhelw D.S. | |
dc.contributor.author | El-Sayed M. | |
dc.contributor.author | Esmat G. | |
dc.contributor.author | Abdelaziz A.I. | |
dc.contributor.other | Department of Pharmacology and Toxicology | |
dc.contributor.other | Molecular Pathology Research Group | |
dc.contributor.other | German University in Cairo | |
dc.contributor.other | New Cairo City Main Entrance Al Tagamoa Al Khames | |
dc.contributor.other | Cairo | |
dc.contributor.other | Egypt; Scientific Affairs Unit | |
dc.contributor.other | Egyptian Company for Biological Sciences | |
dc.contributor.other | Giza | |
dc.contributor.other | Egypt; Faculty of Biotechnology | |
dc.contributor.other | October University of Modern Sciences and Arts | |
dc.contributor.other | Giza | |
dc.contributor.other | Egypt; Endemic Medicine and Hepatology | |
dc.contributor.other | Cairo UniversityCairo | |
dc.contributor.other | Egypt; Biotechnology Graduate Program | |
dc.contributor.other | American University in Cairo | |
dc.contributor.other | AUC Avenue | |
dc.contributor.other | New Cairo | |
dc.contributor.other | Cairo | |
dc.contributor.other | Egypt | |
dc.date.accessioned | 2020-01-09T20:41:22Z | |
dc.date.available | 2020-01-09T20:41:22Z | |
dc.date.issued | 2017 | |
dc.description | Scopus | |
dc.description.abstract | Hepatitis C Virus (HCV) promotes lipid droplet (LD) formation and perturbs the expression of the LD associated PAT proteins ADRP and TIP47, to promote its own lifecycle. HCV enhances TIP47 and suppresses ADRP by displacing it from LD surface in infected cell models. We have previously shown that suppression of TIP47 by miR-148a and miR-30a decreased intracellular LDs and HCV RNA. Thus, this study aimed at examining whether this microRNA-mediated suppression of HCV would limit HCV-dependent displacement of ADRP from LDs. ADRP expression was examined in 21 HCV-infected liver biopsies and 9 healthy donor liver tissues as well as in HCV-infected Huh7 cells using qRT-PCR. miR-148a and miR-30a expression was manipulated using specific oligos in JFH-1 infected, oleic acid treated cells, to study their impact on ADRP expression using qRT-PCR, and immunofluorescence microscopy. Intracellular HCV RNA was assessed using qRT-PCR. ADRP is down regulated in patients as well as HCVcc-JFH-I infected cell models. Forcing the expression of both miRNAs induced ADRP on the mRNA and protein levels. This study shows that HCV suppresses hepatic ADRP expression in infected patients and cell lines. Forcing the expression of miR-148a and miR-30a limits the suppressive effect of HCV on ADRP. J. Med. Virol. 89:653 659, 2017. 2016 Wiley Periodicals, Inc. 2016 Wiley Periodicals, Inc. | en_US |
dc.identifier.doi | https://doi.org/10.1002/jmv.24677 | |
dc.identifier.doi | PubMedID27591428 | |
dc.identifier.issn | 1466615 | |
dc.identifier.other | https://doi.org/10.1002/jmv.24677 | |
dc.identifier.other | PubMedID27591428 | |
dc.identifier.uri | https://t.ly/DXGn2 | |
dc.language.iso | English | en_US |
dc.publisher | John Wiley and Sons Inc. | en_US |
dc.relation.ispartofseries | Journal of Medical Virology | |
dc.relation.ispartofseries | 89 | |
dc.subject | lipids | en_US |
dc.subject | liver | en_US |
dc.subject | microRNAs | en_US |
dc.subject | PAT proteins | en_US |
dc.subject | viral infection | en_US |
dc.subject | adipophilin | en_US |
dc.subject | mannose 6 phosphate receptor binding protein 1 | en_US |
dc.subject | microRNA | en_US |
dc.subject | microRNA 148a | en_US |
dc.subject | microRNA 30a | en_US |
dc.subject | unclassified drug | en_US |
dc.subject | virus RNA | en_US |
dc.subject | adipophilin | en_US |
dc.subject | mannose 6 phosphate receptor binding protein 1 | en_US |
dc.subject | microRNA | en_US |
dc.subject | MIRN148 microRNA, human | en_US |
dc.subject | MIRN30 microRNA, human | en_US |
dc.subject | PLIN2 protein, human | en_US |
dc.subject | PLIN3 protein, human | en_US |
dc.subject | virus RNA | en_US |
dc.subject | ADRP gene | en_US |
dc.subject | adult | en_US |
dc.subject | aged | en_US |
dc.subject | Article | en_US |
dc.subject | clinical article | en_US |
dc.subject | controlled study | en_US |
dc.subject | down regulation | en_US |
dc.subject | female | en_US |
dc.subject | gene expression | en_US |
dc.subject | gene function | en_US |
dc.subject | hepatitis C | en_US |
dc.subject | human | en_US |
dc.subject | human cell | en_US |
dc.subject | human tissue | en_US |
dc.subject | immunofluorescence microscopy | en_US |
dc.subject | male | en_US |
dc.subject | middle aged | en_US |
dc.subject | protein expression | en_US |
dc.subject | reverse transcription polymerase chain reaction | en_US |
dc.subject | antagonists and inhibitors | en_US |
dc.subject | biopsy | en_US |
dc.subject | cell line | en_US |
dc.subject | fluorescence microscopy | en_US |
dc.subject | gene expression profiling | en_US |
dc.subject | Hepacivirus | en_US |
dc.subject | hepatitis C | en_US |
dc.subject | host pathogen interaction | en_US |
dc.subject | liver | en_US |
dc.subject | liver cell | en_US |
dc.subject | metabolism | en_US |
dc.subject | pathogenicity | en_US |
dc.subject | pathology | en_US |
dc.subject | real time polymerase chain reaction | en_US |
dc.subject | virology | en_US |
dc.subject | Adult | en_US |
dc.subject | Biopsy | en_US |
dc.subject | Cell Line | en_US |
dc.subject | Female | en_US |
dc.subject | Gene Expression Profiling | en_US |
dc.subject | Hepacivirus | en_US |
dc.subject | Hepatitis C | en_US |
dc.subject | Hepatocytes | en_US |
dc.subject | Host-Pathogen Interactions | en_US |
dc.subject | Humans | en_US |
dc.subject | Liver | en_US |
dc.subject | Male | en_US |
dc.subject | MicroRNAs | en_US |
dc.subject | Microscopy, Fluorescence | en_US |
dc.subject | Middle Aged | en_US |
dc.subject | Perilipin-2 | en_US |
dc.subject | Perilipin-3 | en_US |
dc.subject | Real-Time Polymerase Chain Reaction | en_US |
dc.subject | RNA, Viral | en_US |
dc.title | miR-148a and miR-30a limit HCV-dependent suppression of the lipid droplet protein, ADRP, in HCV infected cell models | en_US |
dc.type | Article | en_US |
dcterms.isReferencedBy | Asselah, T., Rubbia-Brandt, L., Marcellin, P., Negro, F., Steatosis in chronic hepatitis C: Why does it really matter (2006) Gut, 55, pp. 123-130; Bickel, P.E., Tansey, J.T., Welte, M.A., PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores (2009) Biochim Biophys Acta, 1791, pp. 419-440; Boulant, S., Targett-Adams, P., McLauchlan, J., Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus (2007) J Gen Virol, 88, pp. 2204-2213; Boulant, S., Douglas, M.W., Moody, L., Budkowska, A., Targett-Adams, P., McLauchlan, J., Hepatitis C virus core protein induces lipid droplet redistribution in a microtubule- and dynein-dependent manner (2008) Traffic, 9, pp. 1268-1282; El-Ekiaby, N.M., Mekky, R.Y., El Sobky, S.A., Elemam, N.M., El-Sayed, M., Esmat, G., Abdelaziz, A.I., Epigenetic harnessing of HCV via modulating the lipid droplet-protein, TIP47, in HCV cell models (2015) FEBS Lett, 589, pp. 2266-2273; Gosert, R., Egger, D., Lohmann, V., Bartenschlager, R., Blum, H.E., Bienz, K., Moradpour, D., Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons (2003) J Virol, 77, pp. 5487-5492; Li, Q., Hepatitis C virus infection activates an innate pathway involving IKK-alpha in lipogenesis and viral assembly (2013) Nat Med, 19, pp. 722-729; Miyanari, Y., Atsuzawa, K., Usuda, N., Watashi, K., Hishiki, T., Zayas, M., Bartenschlager, R., Shimotohno, K., The lipid droplet is an important organelle for hepatitis C virus production (2007) Nat Cell Biol, 9, pp. 1089-1097; Ploen, D., Hafirassou, M.L., Himmelsbach, K., Sauter, D., Biniossek, M.L., Weiss, T.S., Baumert, T.F., Hildt, E., TIP47 plays a crucial role in the life cycle of hepatitis C virus (2013) J Hepatol, 58, pp. 1081-1088; Sato, R., Sterol metabolism and SREBP activation (2010) Arch Biochem Biophys, 501, pp. 177-181; Sato, S., Fukasawa, M., Yamakawa, Y., Natsume, T., Suzuki, T., Shoji, I., Aizaki, H., Nishijima, M., Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein (2006) J Biochem, 139, pp. 921-930; Vogt, D.A., Camus, G., Herker, E., Webster, B.R., Tsou, C.L., Greene, W.C., Yen, T.S., Ott, M., Lipid droplet-binding protein TIP47 regulates hepatitis C Virus RNA replication through interaction with the viral NS5A protein (2013) PLoS Pathog, 9; Waris, G., Felmlee, D.J., Negro, F., Siddiqui, A., Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress (2007) J Virol, 81, pp. 8122-8130; Whittaker, R., Loy, P.A., Sisman, E., Suyama, E., Aza-Blanc, P., Ingermanson, R.S., Price, J.H., McDonough, P.M., Identification of MicroRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening (2010) J Biomol Screen, 15, pp. 798-805; Xu, G., Sztalryd, C., Lu, X., Tansey, J.T., Gan, J., Dorward, H., Kimmel, A.R., Londos, C., Post-translational regulation of adipose differentiation-related protein by the ubiquitin/proteasome pathway (2005) J Biolchem, 280, pp. 42841-42847 | |
dcterms.source | Scopus |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- avatar_scholar_128.png
- Size:
- 2.73 KB
- Format:
- Portable Network Graphics
- Description: